These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24711341)

  • 1. Planar microdevices for enhanced in vivo retention and oral bioavailability of poorly permeable drugs.
    Chirra HD; Shao L; Ciaccio N; Fox CB; Wade JM; Ma A; Desai TA
    Adv Healthc Mater; 2014 Oct; 3(10):1648-54. PubMed ID: 24711341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-reservoir bioadhesive microdevices for independent rate-controlled delivery of multiple drugs.
    Chirra HD; Desai TA
    Small; 2012 Dec; 8(24):3839-46. PubMed ID: 22962019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery.
    Ahmed A; Bonner C; Desai TA
    J Control Release; 2002 Jun; 81(3):291-306. PubMed ID: 12044568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging microtechnologies for the development of oral drug delivery devices.
    Chirra HD; Desai TA
    Adv Drug Deliv Rev; 2012 Nov; 64(14):1569-78. PubMed ID: 22981755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.
    Gourdon B; Chemin C; Moreau A; Arnauld T; Baumy P; Cisternino S; Péan JM; Declèves X
    Int J Pharm; 2017 Aug; 529(1-2):357-370. PubMed ID: 28705621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picoliter-volume inkjet printing into planar microdevice reservoirs for low-waste, high-capacity drug loading.
    Fox CB; Nemeth CL; Chevalier RW; Cantlon J; Bogdanoff DB; Hsiao JC; Desai TA
    Bioeng Transl Med; 2017 Mar; 2(1):9-16. PubMed ID: 28503662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
    Attia IA; El-Gizawy SA; Fouda MA; Donia AM
    AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
    Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
    Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
    Paul S; Kumar A; Yedurkar P; Sawant K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1809-17. PubMed ID: 23281917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir.
    Al-Dhubiab BE; Nair AB; Kumria R; Attimarad M; Harsha S
    Colloids Surf B Biointerfaces; 2015 Dec; 136():878-84. PubMed ID: 26547315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS).
    Patel D; Sawant KK
    Drug Dev Ind Pharm; 2007 Dec; 33(12):1318-26. PubMed ID: 18097805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interesting Case of Acyclovir Delivered Using Chitosan in Humans: Is it a Drug Issue or Formulation Issue?
    Srinivas NR
    Pharm Res; 2016 Mar; 33(3):543-7. PubMed ID: 26474764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-Printed Radiopaque Microdevices with Enhanced Mucoadhesive Geometry for Oral Drug Delivery.
    Chang TJ; Kjeldsen RB; Christfort JF; Vila EM; Alstrøm TS; Zór K; Hwu ET; Nielsen LH; Boisen A
    Adv Healthc Mater; 2023 Feb; 12(4):e2201897. PubMed ID: 36414017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoboehmite as a drug delivery system for acyclovir.
    Peres RM; Sousa JML; de Oliveira MO; Rossi MV; de Oliveira RR; de Lima NB; Bernussi A; Warzywoda J; Sarmento B; Munhoz AH
    Sci Rep; 2021 Jul; 11(1):15448. PubMed ID: 34326377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planar bioadhesive microdevices: a new technology for oral drug delivery.
    Fox CB; Chirra HD; Desai TA
    Curr Pharm Biotechnol; 2014; 15(7):673-83. PubMed ID: 25219863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.
    Wade JS; Desai TA
    Biomed Microdevices; 2014 Aug; 16(4):629-38. PubMed ID: 24789225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability.
    Ghosh PK; Majithiya RJ; Umrethia ML; Murthy RS
    AAPS PharmSciTech; 2006 Sep; 7(3):77. PubMed ID: 17025257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
    Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Microdevice Geometry on Transit and Retention in the Murine Gastrointestinal Tract.
    Lykins WR; Hansen ME; Sun X; Advincula R; Finbloom JA; Jain AK; Zala Y; Ma A; Desai TA
    ACS Biomater Sci Eng; 2023 Jun; 9(6):2891-2901. PubMed ID: 33914503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF; Hombach J; Bernkop-Schnürch A
    Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.